EVO - Evotec SE reports 1H results; updates FY22 guidance and mid-term targets of 2025 confirmed

August, 11 2022 02:03 AM Evotec SE

Evotec SE press release ( NASDAQ: EVO ): 1H Revenue of €336.9M (+24.2% Y/Y).
Reported adjusted Group EBITDA totalled €33.6 m (H1 2021: €36.2 m); excellent Group gross margin increasing by 270 bps to 27.3%.
Outlook for FY2022 redefine and mid-term targets of 2025 confirmed : Group revenues now expected to be in a range of €715M - €735M versus €700M - €720M previously (unchanged at €690M - €710M at constant exchange rates) (2021: €618M).
Adjusted Group EBITDA expected to be unchanged in the range of €105M - €120M (new guidance range at constant exchange rates of €85M - €100M versus €95M - €110M previously) (2021: €107M).
Unpartnered research and development expenses expected to be in a range of €70M - €80M (2021: €58M).
Mid-term goals target revenue growth to more than € 1,000 m, adjusted EBITDA of at least €300M and unpartnered research and development expenses of more than €100M
€715M - €735M versus €700M - €720M previously (unchanged at €690M - €710M at constant exchange rates) (2021: €618M).

For further details see: